WallStreetZenWallStreetZen

NASDAQ: NKTX
Nkarta Inc Stock Forecast, Predictions & Price Target

Analyst price target for NKTX

Based on 5 analysts offering 12 month price targets for Nkarta Inc.
Min Forecast
$13.00+99.08%
Avg Forecast
$18.40+181.78%
Max Forecast
$25.00+282.85%

Should I buy or sell NKTX stock?

Based on 5 analysts offering ratings for Nkarta Inc.
Strong Buy
Strong Buy
2 analysts 40%
Buy
3 analysts 60%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their NKTX stock forecasts and price targets.

NKTX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-05-13
lockedlocked$00.00+00.00%2024-05-13
lockedlocked$00.00+00.00%2024-05-10
lockedlocked$00.00+00.00%2024-03-22
lockedlocked$00.00+00.00%2024-03-22

1 of 1

Forecast return on equity

Is NKTX forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
34.39%

Forecast return on assets

Is NKTX forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

NKTX revenue forecast

What is NKTX's revenue in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
$150.0M
Avg 2 year Forecast
$35.7M
Avg 3 year Forecast
$114.1M

NKTX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
NKTX$6.53$18.40+181.78%Strong Buy
TVTX$6.06$13.17+117.28%Buy
VYGR$8.43$18.00+113.52%Strong Buy
EDIT$5.62$12.00+113.52%Buy
CBUS$18.50$25.00+35.14%Buy

Nkarta Stock Forecast FAQ

Is Nkarta Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 5 Wall Street analysts covering (NASDAQ: NKTX) stock is to Strong Buy NKTX stock.

Out of 5 analysts, 2 (40%) are recommending NKTX as a Strong Buy, 3 (60%) are recommending NKTX as a Buy, 0 (0%) are recommending NKTX as a Hold, 0 (0%) are recommending NKTX as a Sell, and 0 (0%) are recommending NKTX as a Strong Sell.

If you're new to stock investing, here's how to buy Nkarta stock.

What is NKTX's revenue growth forecast for 2026-2028?

(NASDAQ: NKTX) Nkarta's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.19%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.95%.

Nkarta's revenue in 2024 is $0.On average, 1 Wall Street analysts forecast NKTX's revenue for 2026 to be $10,570,143,000, with the lowest NKTX revenue forecast at $10,570,143,000, and the highest NKTX revenue forecast at $10,570,143,000. On average, 2 Wall Street analysts forecast NKTX's revenue for 2027 to be $2,512,170,653, with the lowest NKTX revenue forecast at $584,881,246, and the highest NKTX revenue forecast at $4,439,460,060.

In 2028, NKTX is forecast to generate $8,040,144,039 in revenue, with the lowest revenue forecast at $777,962,525 and the highest revenue forecast at $15,908,065,215.

What is NKTX's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: NKTX) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is NKTX's Price Target?

According to 5 Wall Street analysts that have issued a 1 year NKTX price target, the average NKTX price target is $18.40, with the highest NKTX stock price forecast at $25.00 and the lowest NKTX stock price forecast at $13.00.

On average, Wall Street analysts predict that Nkarta's share price could reach $18.40 by May 13, 2025. The average Nkarta stock price prediction forecasts a potential upside of 181.78% from the current NKTX share price of $6.53.

What is NKTX's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: NKTX) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.